Trial Profile
Concurrent Chemoradiation Versus Induction Docetaxel, Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy in Locally Advanced Hypopharyngeal and Base of Tongue Cancer: A Randomized Phase II Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2019
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Hypopharyngeal cancer; Tongue cancer
- Focus Therapeutic Use
- 12 Sep 2017 Status changed from active, no longer recruiting to discontinued, as per an abstract presented at the 42nd European Society for Medical Oncology Congress
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 19 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.